We Can Medicines Co., Ltd.(TW:6929)
NT$21.15+0.30 (+1.44%)
TW:6929
We Can Medicines Co., Ltd. financials statements
NT$21.15
At close:+0.30 (+1.44%)
We Can Medicines Co., Ltd. (6929) Income Statement
We Can Medicines Co., Ltd. Income Statement
Last quarter (Q2 2026), We Can Medicines Co., Ltd.'s total revenue was NT$802.61M, a decrease of 1.74% from the same quarter last year. In Q2, We Can Medicines Co., Ltd.'s net income was NT$-14.29M. See We Can Medicines Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 3.22B | NT$ 3.27B | NT$ 3.12B | NT$ 3.30B | NT$ 2.79B | |
| NT$ 747.34M | NT$ 1.10B | NT$ 1.02B | NT$ 1.11B | NT$ 916.55M | |
| NT$ 815.36M | NT$ 1.15B | NT$ 1.02B | NT$ 990.45M | NT$ 886.13M | |
| Depreciation and Amortization | NT$ 320.70M | NT$ 309.08M | NT$ 276.18M | NT$ 253.54M | NT$ 213.76M |
| NT$ 252.68M | NT$ 288.21M | NT$ 321.25M | NT$ 393.76M | NT$ 266.99M | |
| NT$ -68.02M | NT$ -50.13M | NT$ 42.66M | NT$ 144.16M | NT$ 53.32M | |
| NT$ -5.17M | NT$ 1.72M | NT$ -21.06M | NT$ -23.03M | NT$ -14.53M | |
| NT$ -73.19M | NT$ -48.29M | NT$ 21.60M | NT$ 121.13M | NT$ 38.79M | |
| NT$ -73.21M | NT$ -47.18M | NT$ 14.80M | NT$ 100.05M | NT$ 38.79M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.63 | NT$ -1.09 | NT$ 0.37 | NT$ 2.50 | NT$ 0.97 |
| Diluted EPS | NT$ -1.63 | NT$ -1.09 | NT$ 0.35 | NT$ 2.40 | NT$ 0.97 |
| Weighted Average Shares Outstanding | 45.01M | 43.28M | 40.01M | 40.00M | 39.99M |
| Weighted Average Shares Outstanding (Diluted) | 45.01M | 43.28M | 42.25M | 41.72M | 39.99M |
Currency in TWD
